Prevalence and Profile of Tapentadol Use in Patients Visiting a Drug De-addiction Center in Kashmir
Prevalence and Profile of Tapentadol Use in Patients Visiting a Drug De-addiction Center in Kashmir
About this item
Full title
Author / Creator
Publisher
India: Wolters Kluwer - Medknow
Journal title
Language
English
Formats
Publication information
Publisher
India: Wolters Kluwer - Medknow
Subjects
More information
Scope and Contents
Contents
Background:
Misuse of prescription opioids has been a hazard lately with tapentadol being a recent addition to the list. Tapentadol is a schedule H1 opioid (Drugs and Cosmetics Rules, India), approved for the management of moderate-to-severe acute and chronic pain.
Aims and Objectives:
We examined the prevalence of tapentadol use among pat...
Alternative Titles
Full title
Prevalence and Profile of Tapentadol Use in Patients Visiting a Drug De-addiction Center in Kashmir
Authors, Artists and Contributors
Identifiers
Primary Identifiers
Record Identifier
TN_cdi_doaj_primary_oai_doaj_org_article_4dd63db37a3349298a0492425fccc0ca
Permalink
https://devfeature-collection.sl.nsw.gov.au/record/TN_cdi_doaj_primary_oai_doaj_org_article_4dd63db37a3349298a0492425fccc0ca
Other Identifiers
ISSN
0971-9962
E-ISSN
2454-8316
DOI
10.4103/ijsp.ijsp_12_23
